Financials
Financial year 2026
Worth noting
- A loss two years in a row.
Gross margin
€ -4,700
▲ 41% vs 2025
Profit
Caution€ -4,700
▲ 45% vs 2025
Debts
Normal€ 78,960
▲ 16% vs 2025
AVALO THERAPEUTICS EUROPE from Brussel, company number BE0716860484, closed financial year 2026 with a result of € -4,700 after tax. For that financial year AVALO THERAPEUTICS EUROPE recorded a gross margin of € -4,700 and equity of € 16,916. Compared with financial year 2025, the result moved from € -8,519 to € -4,700. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.
What happened at AVALO THERAPEUTICS EUROPE?
What happened at AVALO THERAPEUTICS EUROPE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: loss of € 4,700. Source: NBB ↗
- Ann Dhoore became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 8,550 loss in 2022 to € 4,700 loss in 2026.
A new publication or filing at AVALO THERAPEUTICS EUROPE? We notify you, reason included.
Follow AVALO THERAPEUTICS EUROPENeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind AVALO THERAPEUTICS EUROPE is Ann Dhoore. Ann Dhoore is also behind maatWERKbedrijf BWB.
Directors
According to the 2026 annual accounts
since 2024
Establishments
Establishment units
Physical locations of this company
Barricadenplein 13
1000 Brussel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 18 companies are registered at this address.
Société Coopérative pour le Développement Industriel en Afrique
Société des Habitations à Bon Marché
Domein van Vorselaar
€ 182,308 gross margin · 2025
DE BEUKEN
€ -14,127 gross margin · 2025
MERISANT EUROPE
€ 66,970 gross margin · 2025
+13 more
Details
- Company number
- 0716.860.484
- VAT number
- BE 0716.860.484
- Registered office
- Barricadenplein 13, 1000 Brussel
- Names & denominations
- AVALO THERAPEUTICS EUROPE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 December 2018
- Peppol
- Not registered